← Back to list
MA07.024g, Medical and Surgical Treatment of Temporomandibular Joint Disorder
Effective date
Feb 26, 2024
Identified
Oct 29, 2026
Summary
Independence Blue Cross has reissued Medicare Advantage Medical Policy MA07.024g on 10/28/2026 to communicate its continuing position on medical and surgical treatment of temporomandibular joint disorder. This is a reissue with minor changes confirming existing coverage criteria; no new substantive changes to billing, coding, or medical necessity requirements were introduced in this 2026 update. The policy remains effective as of 02/26/2024 with previously established coverage for physical therapy, injections, biofeedback, and surgical interventions when medical necessity criteria are met.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Get Independence Blue Cross alertsPolicy Monitoring is free. No card required.
What to do
Action · 4 steps
01Already effective 02/26/2024: This policy reissue on 10/28/2026 communicates Independence Blue Cross's continuing position on TMD treatment coverage.
02Billing team should verify that current billing procedures and system configurations comply with the established medical necessity criteria (including requirements for documented treatment plans, trial of at least one medical therapy before surgical consideration, and radiologic confirmation for most surgical procedures).
03No new deadlines or implementation requirements are stated in this reissue.
04Confirm current applicability of all covered codes and procedures listed in the policy against your active billing workflows.
Codes mentioned
97024971109711297124971402105097799L8699D7880D7881D9942D9950M26.601M26.602M26.603M26.609M26.611M26.612M26.613M26.619M26.621
Original notice
MA07.024g, Medical and Surgical Treatment of Temporomandibular Joint Disorder
medpolicy.ibx.com · Always check the source before changing claims.
Related changes
See all Independence Blue Cross changes →07.08.03i, Medical and Surgical Treatment of Temporomandibular Joint DisorderLowEffective Feb 26, 2024 · Medical Policy11.14.02s, Trigger Point InjectionsMediumEffective Apr 1, 2025 · PharmacyMA07.024g, Medical and Surgical Treatment of Temporomandibular Joint DisorderMediumEffective Feb 26, 2024 · Medical Policy07.08.03i, Medical and Surgical Treatment of Temporomandibular Joint DisorderMediumEffective Feb 26, 2024 · Medical PolicyBrowse every Independence Blue Cross change in the policy list
Related policy hubs
Independence Blue Cross policiesDentistryOral & Maxillofacial SurgeryPhysical TherapyPain ManagementGeneral SurgeryCode 97024Code 97110Code 97112Code 97124Code 97140Code 21050Code 97799Code L8699Code D7880Code D7881Code D9942Code D9950Code M26.601Code M26.602Code M26.603Code M26.609Code M26.611Code M26.612Code M26.613Code M26.619Code M26.621